Filing Details
- Accession Number:
- 0000874015-13-000093
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-08-13 19:45:10
- Reporting Period:
- 2013-08-09
- Filing Date:
- 2013-08-13
- Accepted Time:
- 2013-08-13 19:45:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874015 | Isis Pharmaceuticals Inc | ISIS | Pharmaceutical Preparations (2834) | 330336973 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1206369 | Iii Joseph Klein | C/O Isis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad CA 92010 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-08-09 | 103 | $13.88 | 8,416 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-08-09 | 103 | $28.23 | 8,313 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-08-09 | 3,647 | $13.88 | 11,960 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-08-09 | 3,647 | $28.22 | 8,313 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-08-09 | 7,500 | $9.30 | 15,813 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-08-09 | 7,500 | $28.22 | 8,313 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-08-09 | 7,500 | $9.22 | 15,813 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-08-09 | 7,500 | $28.22 | 8,313 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Director Stock Option (right to buy) | Disposition | 2013-08-09 | 3,750 | $0.00 | 3,750 | $13.88 |
| Common Stock | Director Stock Option (right to buy) | Disposition | 2013-08-09 | 7,500 | $0.00 | 7,500 | $9.22 |
| Common Stock | Director Stock Option (right to buy) | Disposition | 2013-08-09 | 7,500 | $0.00 | 7,500 | $9.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2012-07-01 | 2018-06-30 | No | 4 | M | Direct |
| 3,750 | 2013-07-01 | 2020-06-30 | No | 4 | M | Direct |
| 7,500 | 2012-07-01 | 2021-06-30 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 100 | Indirect | By Son |
Footnotes
- Grant of 7/1/10 to reporting person of stock options under the Isis Pharmaceuticals, Inc. 2002 Non Employee Directors' Stock Option Plan. The option vests and becomes exercisable in four equal annual installments, the first installment vesting on 7/1/11. The option shall be fully vested and exercisable on 7/1/2014. The option is exercisable as to 7,500 shares on 8/9/13.
- Grant of 7/1/11 to reporting person of stock options under the Isis Pharmaceuticals, Inc. 2002 Non Employee Directors' Stock Option Plan. The option vests and becomes exercisable in four equal annual installments, the first installment vesting on 7/1/12. The option shall be fully vested and exercisable on 7/1/2015. The option is exercisable as to 7,500 shares on 8/9/13.
Billionaire Hedge Funds
